Physician response to implementation of genotype-tailored antiplatelet therapy.

Peterson JF, Field JR, Unertl KM, Schildcrout JS, Johnson DC, Shi Y, Danciu I, Cleator JH, Pulley JM, McPherson JA, Denny JC, Laposata M, Roden DM, Johnson KB
Clin Pharmacol Ther. 2016 100 (1): 67-74

PMID: 26693963 · PMCID: PMC4899238 · DOI:10.1002/cpt.331

MeSH Terms (18)

Aged Age Factors Clinical Decision-Making Clopidogrel Cytochrome P-450 CYP2C19 Female Genetic Variation Genotype Humans Male Middle Aged Pharmacogenetics Platelet Aggregation Inhibitors Practice Patterns, Physicians' Precision Medicine Prospective Studies Stents Ticlopidine

Connections (2)

This publication is referenced by other Labnodes entities: